Clinical Trial Environmental Impact
CMC Ontology
Data FAIRy Bioassay Annotation
Global Substance Registration System
IDMP Ontology
In Vitro NAM Data Standards
In Vitro Pharmacology
Large Language Models in Life Sciences
NLP Use Case Database
Pharma General Ontology
Pharmacovigilance Systems and Processes Standards
Social Media Real World Evidence
Current Projects
Delivered Projects
AI / ML
Change Management
CSCS
Data Governance
FAIR
Future Labs Evolution
Microbiome-Mediated Drug Metabolism Database
Quantum Computing
UXLS
Current Communities
Delivered Communities
Delivered Projects and Communities
New Ideas
Username or Email Address
Password
Remember Me
Webinar
In this discussion, the UXLS project unveils the first draft of the Data and UX heuristics which have been crafted to support UX designers working on data-driven projects.
In 2020, a team of scientists from AstraZeneca, Bristol Myers Squibb, Novartis, and Roche set forth to find a way to convert unstructured biological assay descriptions into FAIR information objects.
Roche, as a leading biopharmaceutical company, has a diverse and distributed ecosystem of platforms to manage reference data standards used at different parts of the organization. Lynx is a FAIR-fueled system to enable seamless access across that ecosystem.
This presentation will provide practical recommendations on how to put the tsunami of RWE and data variety to work using the IMPACT framework.
Imaging biomarkers are an ideal method for drawing evidence from retrospective data and can be used both as inclusion criteria, to select relevant cohorts of patients, and as output data, to quantify responses to treatments
Blockchain technology puts patients in control of their identity and their data and has the potential to significantly change how patients are enrolled and participate in clinical trials.
Our speakers, Drs. Aleksandar Poleksic and Lei Xie, describe two new computational techniques for prediction of the differential gene expression profiles perturbed by de novo chemicals and inference of drug-disease associations.
Join us for this webinar where we will hear from a number of our project members on their approaches to scale UX in their organizations and product lines.
This webinar provided an overview of the state of play around Brexit and the impact on international pharmaceutical research.
AI models are used increasingly often in the development of pharmaceuticals and as software components in medical devices. However, due to a lack of clear reporting standards, many clinically relevant models have been reported with insufficient details to properly assess their risks and benefits.
What's the structure of that biomolecule?
Design Systems are not only a classification of components, but a whole process that is built and maintained by a company to help them develop superior user experiences and strengthen their brand.
